miRNome in myocardial infarction: Future directions and perspective

Abstract

MicroRNAs (miRNAs), which are small and non-coding RNAs, are genome encoded from viruses to humans. They contribute to various developmental, physiological and pathological processes in living organisms. A huge amount of research results revealed that miRNAs regulate these processes also in the heart. miRNAs may have cell-type-specific or tissue-specific expression patterns or may be expressed ubiquitously. Primary studies of miRNA involvement in hypertrophy, heart failure and myocardial infarction analyzed miRNAs that are enriched in or specific for cardiomyocytes; however, growing evidence suggest that other miRNAs, not cardiac or muscle-specific, play a significant role in cardiovascular disease. Abnormal miRNA regulation has been shown to be involved in cardiac diseases, suggesting that miRNAs might affect cardiac structure and function. In this review, we focus on miRNAs that have been found to contribute to the pathogenesis of myocardial infarction (MI) and the response post-MI and characterized as diagnostic, prognostic and therapeutic targets. The majority of these studies were performed using mouse and rat models of MI, with a focus on the identification of basic cellular and molecular pathways involved in MI and in the response post-MI. Much research has also been performed on animal and human plasma samples from MI individuals to identify miRNAs that are possible prognostic and/or diagnostic targets of MI and other MI-related diseases. A large proportion of research is focused on miRNAs as promising therapeutic targets and biomarkers of drug responses and/or stem cell treatment approaches. However, only a few studies have described miRNA expression in human heart tissue following MI.© 2014 Baishideng Publishing Group Inc. All rights reserved.Key words: MicroRNAs; Myocardial infarction; Human; Animal models; Biomarkers and targets Core tip: MicroRNAs (miRNAs) contribute to various developmental, physiological and pathological processes in the heart. Cardiac diseases show abnormal miRNA regulation. Primary studies of miRNA involvement in cardiac disease analyzed mainly miRNAs that enriched in or specific for cardiomyocytes; however, growing evidence suggests that other cell-type-specific or ubiquitously expressed miRNAs are also involved in cardiovascular disease. miRNAs were found to contribute to the pathogenesis of myocardial infarction (MI) and post-MI. The majority of studies focused on miRNAs in animal models of MI, in human and animal plasma samples of MI (prognostic and diagnostic targets), and on miRNAs as promising therapeutic targets.Boštjančič E, Glavač D. miRNome in myocardial infarction: Future directions and perspective. World J Cardiol 2014; 6(9): 939-958 Available from:

Molecular Regulation of Mirnas and Potential Biomarkers in the Progression of Hepatic Steatosis to NASH

“…For instance, a cluster of miRNAs-17-92 is typically expressed in human B-cell lymphomas [16]. Moreover, overexpression of miR-195 during cardiac hypertrophy results in pathological cardiac growth and heart failure, while miR-199a is expressed in cardiomyocytes where it maintains cell size Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH future science group Review Wang, Liu, Zou, Hong, Fang & Tong and plays a role in the regulation of cardiac hypertrophy [17]. Such miRNA expression signatures may be able to differentiate human malignancies according to their developmental origin, which has important clinical implications.…”

MicroRNAs in Disease

“…The use of miRNAs as biomarkers in CVDs has also been extensively explored (reviewed in [ 157 ]). Myocardial damage is characterized by a release of miR-208b and miR-499 into circulation and the prognostic value of both miRNAs is under study [ 158 ].…”

Novel approaches of pharmacological preconditioning: the role of biglycan and miRNAs

“…Growing evidence suggests an important role of miRNAs in various physiological and pathological processes in the heart including cardiac development, myocyte contractility and cellular response to different stress; and altered and abnormal miRNA expression has been linked to a wide range of diseases, including cardiovascular diseases like AMI [83,86]. Numerous miRNAs have been shown to be involved in cardiomyocyte survival in response to hypoxia by regulating key survival or cardioprotective genes [85].…”

“…The main mechanism of their action is the posttranscriptional repression of gene expression by sequence-specific binding to the 3'-untranslated region (3'-UTR) of target mRNAs leading to mRNA degradation or protein synthesis repression via translational repression [84]. Due to this mechanism, each miRNA could influence several mRNAs, and the mRNAs often have multiple evolutionarily conserved miRNA-binding sites that provide multiplicity [83].…”

“…The miRNAs are endogenously expressed small -21-25 nucleotides' long -noncoding RNA molecules, encoded in almost all organisms from viruses to humans [83].…”